Medical management of postoperative recurrence in Crohn's disease

被引：29

作者：

Van Assche, G ^{[1
]}

Rutgeerts, P ^{[1
]}

机构：

[1] Katholieke Univ Leuven Hosp, Dept Internal Med, Div Gastroenterol, B-3000 Louvain, Belgium

来源：

GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2004年 / 33卷 / 02期

关键词：

D O I：

10.1016/j.gtc.2004.02.012

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

More than half of Crohn's disease patients require surgery during the course of their disease. Although endoscopic recurrence does not necessarily imply that patients have symptom recurrence, the high need for repeated surgery indicates that lesions gradually developing after surgical remission lead to fibrostenosis or other complications. Despite multiple clinical trials a clear medical strategy to prevent disease recurrence has not been identified. Future well-designed collaborative trials with specified end points are needed to optimize clinical practice in the prevention of postoperative Crohn's disease recurrence.

引用

页码：347 / +

页数：15

共 45 条

[1]

ADLER DJ, 1999, INFLAMM BOWEL DIS, P731

[2] Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis [J].

Baert, FJ ;

D'Haens, GR ;

Peeters, M ;

Hiele, MI ;

Schaible, TF ;

Shealy, D ;

Geboes, K ;

Rutgeerts, PJ .

GASTROENTEROLOGY, 1999, 116 (01) :22-28

[3] Surgical therapy for ulcerative colitis and Crohn's disease [J].

Becker, JM .

GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1999, 28 (02) :371-+

[4]

BERGMAN L, 1976, SCAND J GASTROENTERO, V11, P651

[5] MESALAMINE IN THE PREVENTION OF ENDOSCOPIC RECURRENCE AFTER INTESTINAL RESECTION FOR CROHNS-DISEASE [J].

BRIGNOLA, C ;

COTTONE, M ;

PERA, A ;

ARDIZZONE, S ;

SCRIBANO, ML ;

DEFRANCHIS, R ;

DARIENZO, A ;

DALBASIO, G ;

PENNESTRI, D ;

BELLOLI, C ;

DESIMONE, G ;

GIZZI, G ;

BARBARA, L ;

POGGIOLI, G ;

GOZZETTI, G ;

COTTONE, M ;

CAPPELLO, M ;

OLIVA, L ;

GATTO, G ;

ORLANDO, A ;

ASTEGIANO, M ;

SAMBATARO, A ;

MUSSO, A ;

ARDIZZONE, S ;

DESIDERI, S ;

PRANTERA, C ;

BERTO, E ;

MAZZACCA, G ;

MANGUSO, F ;

DEFRANCHIS, R ;

VECCHI, M ;

DALBASIO, G ;

VANNOZZI, G ;

TRALLORI, G ;

MILLA, M ;

BERRI, F ;

PENNESTRI, D ;

BASSO, O .

GASTROENTEROLOGY, 1995, 108 (02) :345-349

[6] Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables [J].

Camma, C ;

Giunta, M ;

Rosselli, M ;

Cottone, M .

GASTROENTEROLOGY, 1997, 113 (05) :1465-1473

[7] Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: A randomized controlled study vs mesalamine. [J].

Campieri, M ;

Rizzello, F ;

Venturi, A ;

Poggioli, G ;

Ugolini, F ;

Helwig, U ;

Amadini, C ;

Romboli, E ;

Gionchetti, P .

GASTROENTEROLOGY, 2000, 118 (04) :A781-A781

[8]

CAPRILLI R, 1994, ALIMENT PHARM THER, V8, P35

[9] Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease:: a pragmatic, double-blind, randomized controlled trial [J].

Caprilli, R ;

Cottone, M ;

Tonelli, F ;

Sturniolo, G ;

Castiglione, F ;

Annese, V ;

Papi, C ;

Viscido, A ;

Cammà, C ;

Corrao, G ;

Latella, G .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (04) :517-523

[10] Prognostic factors for postoperative recurrence of Crohn's disease [J].

Caprilli, R ;

Corrao, G ;

Taddei, G ;

Tonelli, F ;

Torchio, P ;

Viscido, A ;

Latella, G ;

Frieri, G ;

Vernia, P ;

Lanfranchi, GA ;

Tragnone, A ;

DAlbasio, G ;

Salvadori, G ;

Paladini, I ;

Ficari, F ;

Valpiani, D ;

Rigo, GP ;

Mastronardi, M ;

Codeluppi, PL ;

Sturniolo, GC ;

DInca, R ;

Pallone, F ;

Capurso, L ;

Andreoli, A ;

Gioieni, A ;

Lorenzetti, R ;

Ciaco, A ;

Papi, C ;

Luminari, M ;

Rossini, FP ;

Ponti, V ;

Bertone, A .

DISEASES OF THE COLON & RECTUM, 1996, 39 (03) :335-341

← 1 2 3 4 5 →